Sessioni Poster
Pharmacovigilance
Mercoledì 28 Ottobre 2015 / 19.00-20.00
16 | Sertraline and extrapyramidal effects: an unknown case of dysgraphia Gentili M., Galimberti C., Fusi O., Carnovale C., Marinaccio P., Ba G., Clementi E., Radice S., Viganò C. |
20 | Drug induced progressive multifocal leukoencephalopathy: a comprehensive analysis of the WHO adverse drug reactions database Melis M., Biagi C., Småbrekke L., Nonino F., Buccellato E., Donati M., Vaccheri A., Motola D. |
32 | Safety profile of H1-antihistamines in children: an analysis based on data from VigiBase Biagi C., Donati M., Melis M., Calamelli E., Monaco L., Ricci G., Vaccheri A., Motola D. |
40 | Adverse Drug Reactions, Medication Adherence and Physicians’ Prescribing Behavior: Which relationship? A Database Analysis on Statin Use Leporini C., Degli Esposti L., Sangiorgi D., Ursini F., Scicchitano F., De Sarro G., Russo E. |
59 | Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy Cimmaruta D., Sullo MG., Perri D., Sibilio M., Rafaniello C., Fucile A., Rossi F., Capuano A. |
139 | A simple informative intervention in primary care increases statin adherence Casula M., Tragni E., Piccinelli R., Zambon A., De Fendi L., Scotti L., Corrao G., Gambera M., Catapano AL. |
216 | Comparative safety of antiplatelet agents: a study of “real-world” data from the Italian National Pharmacovigilance Network Gozzo L., Navarria A., Drago V., Longo L., Mansueto S., Pimpinella G., Pani L., Drago F. |
238 | Adverse drug reactions caused by ketorolac off-label use in Italy Viola E., Trifirò G., Sottosanti L., Ingrasciotta Y., Tari M., Gonella LA., Giorgianni F., Lora R., Leone R., Conforti A. |
243 | Biosimilars-induced Adverse Drug Reactions. Analysis of the Italian Pharmacovigilance Database Stoppa G., Opri S., Sottosanti L., Moretti U., Pagliarini M., Conforti A. |
249 | Detection and analysis of medication errors in the Italian Pharmacovigilance Database Magro L., Arzenton E., Viola E., Lora R., Sottosanti L., Capuano A., Sportiello L., Rossi F., Leone R. |
253 | Drug interactions with lithium: long known but still overlooked. An emblematic case. Baggiani G., Chillotti C., Capra C., Bocchetta A. |
255 | Elevation of Clozapine Serum Concentrations: Probable Interaction with Omeprazole Traccis F., Deidda A., Stochino ME., Martinelli V., Squassina A., Congiu D., Bocchetta A. |
314 | Notification of Undesirable Effects and Serious Undesirable Effects to the Italian Ministry of Health according to the Regulation (EC) No. 1223/2009 on cosmetic products (“Cosmetics Regulation”): a two year survey Caputo I., Fabbri E., D'Alessandro P., Sautebin L., Marletta M. |
316 | Interstitial lung disease induced by fluoxetine Deidda A., Lampus S., Bocchetta A., Pisanu C., Micheletto L., Sanna MV., Stochino ME. |
325 | Adverse Reactions to Vaccines Causing Children Admission to the Paediatric Emergency Department: a Single Center Study Mecchio AM., Arcoraci V., Mennito F., Minutoli L., Cutroneo PM., Arrigo T., Altavilla D. |
340 | Agreement between potential drug interactions identified by an electronic tool and clinical judgment: INTERCheck® versus physicians Antoniazzi S., Chiarelli MT., Venturini F., Nobili A., Pasina L., Casiraghi C., Santalucia P., Marcucci M., Damanti S., Periti G., Porzio M., Rossio R., Peyvandi F., Fargion S., Mari D., Monzani V., Mannucci PM. |
343 | Pharmacovigilance active project: biological drugs use in the Policlinico Hospital of the Second University of Naples Fiorentino S., Auricchio F., Bernardi FF., Bonagura AC., Cenami R., Cimmaruta D., Ferrajolo C., Formica R., Limone L., Maccariello A., Mascolo A., Perone I., Rafaniello C., Sessa M., Scavone C., Sportiello L., Sullo MG., Rossi F., Capuano A., Dello Iacono D. |
371 | Paediatric Drug Safety Surveillance in Italian Pharmacovigilance Network: an overview of Adverse Drug Reactions in the years 2001-2012 Ferrajolo C., Capuano A., Rossi F., Moretti U., Trifirò G., Santuccio C. |
379 | Forward (Facilitation Of Reporting in hospital WARD) project: an useful tool to improve the detection, evaluation and reporting of ADRs in hospital setting Macrì R., Sirna V., Giardina C., Anfuso Alberghina M., Tarro P., Garaffo E., Ferrara R., Cutroneo PM., Arcoraci V. |
411 | Multi-medication in an Italian Neonatal Intensive Care Unit: focus on drugs with nephrotoxic potential Girardi A., Raschi E., Poluzzi E., Lorenz M., Galletti S., Faldella G., De Ponti F. |
421 | No neuromuscular block after maximal dose of rocuronium: a case report Maccariello A., Auricchio F., Bernardi F F., Bonagura A C., Cenami R., Cimmaruta D., Ferrajolo C., Fiorentino S., Formica R., Limone L., Mascolo A., Perone I., Rafaniello C., Scavone C., Sessa M., Sportiello L., Sullo M G., Capuano A., Rossi F. |
449 | Pharmacovigilance in oncology: analysis of adverse drug reaction in the last three years Nappi A., Bonagura AC., Spatarella M., Zuppardi P. |
456 | Oncological drug-related adverse events reported in the 'FARMAONCO' database in 2014 at the I.R.C.C.S. San Matteo University Hospital in Pavia Ferrari A., Porta C., Giglione P., Ferraris E., Delfanti S., Paglino C., Perfetti V., Lombardo F., Brugnatelli S., Secondino S., Valentino F., Pagani A., Grasso D., Reversi F., Morabito S., Mariucci S., Imarisio I., Guarnone E., Pedrazzoli P., Calvi M. |
503 | Desirable (possible?) Sustainable Development of Italian Pharmacovigilance System Cosentino E., Peru M. |
506 | A brief overview of pharmacovigilance in the Molise Region: toward a long-awaited change of pace Ambrosino P., Lavalle A., Rea R., Di Lizia B., Soldovieri MV., Russo C., Taglialatela M. |
527 | QT interval prolongation and hydroxyzine: a retrospective cohort analysis on hospitalized elderly patients Montagnani S., Blandizzi C., Marino A., Pasqualetti G., Qasem A., Cottone S., Capogrosso-Sansone A., Mantarro S., Convertino I., Saporiti A., Salvadori S., Fornai M., Antonioli L., Monzani F., Tuccori M. |
531 | Estimation of theoretical cost preventability achievable with an effective pharmacovigilance activity in a Pharmacovigilance Regional Centre in Italy Convertino I., Capogrosso-Sansone A., Mantarro S., Montagnani S., Marino A., Saporiti A., Blandizzi C., Tuccori M. |
542 | Potential and actual drug-drug interactions in elderly patients admitted to an emergency department: data from the ANCESTRAL-ED study Convertino I., Capogrosso-Sansone A., Marino A., Tuccori M., Mantarro S., Montagnani S., Saporiti A., Bini G., Sieli R., Pasqualetti G., Monzani F., Santini M., Blandizzi C. |
576 | Active surveillance on the pediatric antibiotic use in the age group between 0 and 2 years Lavalle A., Rea R., Ambrosino P., di Lizia B., Russo C., Taglialatela M. |
587 | Severe cardiac events following treatment with trastuzumab in women with breast cancer: a meta-analysis of clinical trials and cohort studies Mantarro S., Rossi M., Tuccori M., Capogrosso-Sansone A., Convertino I., Montagnani S., Marino A., Saporiti A., Garibaldi D., D'Amico R., Negri E., La Vecchia C., Moja L., Blandizzi C. |
593 | Evaluation of reporting risk for myopathy using the Italian Adverse Drug Reaction Spontaneous Reporting Database: proton pump inhibitors and their interaction with statins Capogrosso-Sansone A., Galiulo MT., Tuccori M., Mantarro S., Montagnani S., Convertino I., Marino A., Saporiti A., Salvadori S., Fornai M., Antonioli L., Renda F., Blandizzi C. |
657 | PHYTO.VIG.GEST: “Vigilance on use of drugs, herbal products and food supplements during pregnancy”. Preliminar results Mannucci C., Dante G., Miroddi M., Facchinetti F., D'Anna R., Santamaria A., Calapai F., Lenti MC., Vannacci A., Perone M., Navarra M., Calapai G. |
67 | Safety of Antipsychotic Drugs in Paediatric patients Limone L., Auricchio F., Bernardi FF., Bonagura AC., Cenami R., Cimmaruta D., Ferrajolo C., Fiorentino S., Formica R., Maccariello A., Mascolo A., Perone I., Rafaniello C., Scavone C., Sessa M., Sportiello L., Sullo MG., Capuano A. |
368 | Healthcare databases for paediatric studies: a report from the GRiP network global survey Ferrajolo C., Osokogu O., Brauchli Pernus Y., Weibel D., Verhamme KMC., Gazarian M., Wong ICK., Nakamura H., Bonhoeffer J., Giaquinto C., Sturkenboom MCJM. |
732 | The effects of the β-cyclodextrin, as a solubility enhancer, on the efficacy and safety of diclofenac and progesterone formulations Scavone C., Bonagura AC., Fiorentino S., Cenami R., Tortella M., Fossati T., Rossi F. |
733 | Kounis syndrome: an analysis of spontaneous reports from international pharmacovigilance database Renda F., Landoni G., Trotta F., Piras D., Finco G., Felicetti P., Pimpinella G., Pani L. |
349 | The activities of the Ethics Committee of Lecce following the reorganization of the Committees Ethics: Law Balduzzi (189/12) and D.M. 02/08/2013 Romano R., Canitano M., Morciano C., Conte D., Comitato . |
267 | Monitoring of Adverse Events in Paediatrics (MEAP) Project: preliminary results Cenami R., Auricchio F., Bernardi FF., Bonagura AC., Cimmaruta D., Ferrajolo C., Fiorentino S., Formica R., Limone L., Maccariello A., Mascolo A., Perone I., Rafaniello C., Scavone C., Sessa M., Sportiello L., Sullo MG., Rossi F., Capuano A. |